This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

  82R4032 GCB-F
 
  By: Darby H.B. No. 1137
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the transmission of records regarding over-the-counter
  sales of ephedrine, pseudoephedrine, and norpseudoephedrine and a
  person's civil liability for certain acts arising from the sale of
  those products.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 486.014, Health and Safety Code, is
  amended to read as follows:
         Sec. 486.014.  PREREQUISITES TO AND RESTRICTIONS ON SALE.  
  (a)  Before completing an over-the-counter sale of a product
  containing ephedrine, pseudoephedrine, or norpseudoephedrine, a
  business establishment that engages in those sales shall:
               (1)  require the person making the purchase to:
                     (A)  display a driver's license or other form of
  government-issued identification containing the person's
  photograph and indicating that the person is 16 years of age or
  older; and
                     (B)  sign for the purchase;
               (2)  make a record of the sale, including the name and
  date of birth of the person making the purchase, the address of the
  purchaser, the date and time of the purchase, the type of
  identification displayed by the person and the identification
  number, and the item and number of grams purchased; and
               (3)  transmit the record of sale as required by Section
  486.0141.
         (b)  A business establishment may not sell to [take actions
  necessary to prevent] a person who makes over-the-counter purchases
  of one or more products containing ephedrine, pseudoephedrine, or
  norpseudoephedrine:
               (1)  within any calendar day, [from obtaining from the
  establishment in a single transaction] more than:
                     (A)  two packages of those products; or
                     (B)  3.6 [six] grams of ephedrine,
  pseudoephedrine, norpseudoephedrine, or a combination of those
  substances; and
               (2)  within any 30-day period, more than nine grams of
  ephedrine, pseudoephedrine, norpseudoephedrine, or a combination
  of those substances.
         SECTION 2.  Subchapter B, Chapter 486, Health and Safety
  Code, is amended by adding Sections 486.0141, 486.0142, 486.0143,
  and 486.0144 to read as follows:
         Sec. 486.0141.  TRANSMISSION OF SALES INFORMATION TO A
  REAL-TIME ELECTRONIC LOGGING SYSTEM. (a)  Before completing an
  over-the-counter sale of a product containing ephedrine,
  pseudoephedrine, or norpseudoephedrine, a business establishment
  that engages in those sales shall transmit the information in the
  record made under Section 486.014(a)(2) to a real-time electronic
  logging system used by pharmacies and law enforcement agencies and
  personnel, such as the National Precursor Log Exchange, that is
  administered by a nonprofit organization involved in the prevention
  and investigation of prescription drug diversion, such as the
  National Association of Drug Diversion Investigators, if such a
  system is available to the establishment at no cost.
         (b)  A business establishment may not complete an
  over-the-counter sale of a product containing ephedrine,
  pseudoephedrine, or norpseudoephedrine if a real-time electronic
  logging system described in Subsection (a) returns a report that
  the completion of the sale would result in the person obtaining an
  amount of ephedrine, pseudoephedrine, norpseudoephedrine, or a
  combination of those substances greater than the amount described
  by Section 486.014(b), regardless of whether all or some of the
  products previously obtained by the buyer were sold at the
  establishment or another business establishment.
         (c)  The administrators of the real-time electronic logging
  system described in this section shall forward to the Department of
  Public Safety a copy of each record of an over-the-counter sale of a
  product containing ephedrine, pseudoephedrine, or
  norpseudoephedrine that is submitted by a business establishment
  located in this state.
         Sec. 486.0142.  WRITTEN LOG.  If a business establishment
  that engages in over-the-counter sales of a product containing
  ephedrine, pseudoephedrine, or norpseudoephedrine experiences a
  mechanical or electronic failure of the real-time electronic
  logging system, the business shall maintain a written or electronic
  record that satisfies the requirements of Section 486.014(a)(2) and
  enter the information in the electronic logging system as soon as
  practicable after the electronic logging system becomes
  operational.
         Sec. 486.0143.  ONLINE PORTAL. The nonprofit organization
  involved in the prevention and investigation of prescription drug
  diversion described in Section 486.0141 that operates a real-time
  electronic logging system used by pharmacies and law enforcement
  agencies and personnel shall provide real-time access to the
  information in the system to the Department of Public Safety if the
  department executes a memorandum of understanding with the
  nonprofit organization that operates the system.
         Sec. 486.0144.  LIMITATION ON CIVIL LIABILITY. A person is
  not liable for an act or omission arising from the person's
  compliance with the requirements of Section 486.014 or 486.0141.
         SECTION 3.  Not later than September 30, 2011, the Texas
  State Board of Pharmacy and the Department of State Health Services
  shall provide to the nonprofit organization described in Section
  486.0141, Health and Safety Code, as added by this Act, the names,
  addresses, and phone numbers of all pharmacy and retail
  establishments selling over-the-counter products containing
  ephedrine, pseudoephedrine, and norpseudoephedrine.
         SECTION 4.  The changes in law made by this Act apply only to
  an over-the-counter sale of a product containing ephedrine,
  pseudoephedrine, or norpseudoephedrine that is completed on or
  after the effective date of this Act.  An over-the-counter sale of a
  product containing ephedrine, pseudoephedrine, or
  norpseudoephedrine that was completed before the effective date of
  this Act is covered by the law in effect when the sale was
  completed, and the former law is continued in effect for that
  purpose.
         SECTION 5.  (a)  Except as provided by Subsection (b), this
  Act takes effect January 1, 2012.
         (b)  Section 3 of this Act takes effect September 1, 2011.